Results 51 to 60 of about 754 (158)

Exploring geographical variances in component‐resolved diagnosis within the Asia‐Pacific region

open access: yesPediatric Allergy and Immunology, Volume 36, Issue 3, March 2025.
Abstract Component‐resolved diagnostics (CRD) have revolutionized allergy diagnosis, offering enhanced accuracy and insights into allergen sensitization patterns. This review explores geographical variances in CRD for food and aeroallergens across the Asia‐Pacific region.
Carmen Riggioni   +8 more
wiley   +1 more source

Analysis of Helper T Cell Responses to Cry j 1-Derived Peptides in Patients with Nasal Allergy: Candidate for Peptide-Based Immunotherapy of Japanese Cedar Pollinosis

open access: yesAllergology International, 2009
Background: Allergen specific immunotherapy is highly effective, but adverse events may occur during treatment. Peptide-based immunotherapy has been proposed as one of new strategies for reduction of allergic adverse reactions.
Keisuke Masuyama   +6 more
doaj   +1 more source

Chinese expert consensus on allergen component resolved diagnosis

open access: yesPediatric Allergy and Immunology, Volume 35, Issue 11, November 2024.
Abstract Background Allergen component resolved diagnosis (CRD) is a method for identifying specific protein molecules that cause hypersensitivity. Unlike traditional methods that use crude allergen extracts containing multiple component species, CRD focuses on individual allergen protein molecules for more precise diagnosis.
Wenting Luo   +33 more
wiley   +1 more source

Sublingual Immunotherapy for Japanese Cedar Pollinosis

open access: yesNihon Bika Gakkai Kaishi (Japanese Journal of Rhinology), 2010
The prevalence of pollinosis caused by cedar pollen has increased by 10% these ten years of 26.5% in the investigation of 2008 in Japan. The pharmacotherapy is a main treatment tool for pollinosis, and the surgical treatment is not acknowledged to the treatment of pollinosis internationally.
Atsushi Yuta   +2 more
openaire   +3 more sources

Patterns of Drug Prescription for Japanese Cedar Pollinosis Using a Clinical Vignette Questionnaire

open access: yesAllergology International, 2008
Background: Although prescribed drugs directly affect patient outcome, the variation in physicians' attitudes towards drug therapy for cedar pollinosis has not been quantitatively assessed.
Goro Takahashi   +3 more
doaj   +1 more source

The impact of COVID‐19 on hay fever treatment in Japan: A retrospective cohort study based on the Japanese claims database

open access: yesClinical and Translational Allergy, Volume 14, Issue 9, September 2024.
Abstract Background Hay fever (HF) presents with various symptoms, including allergic conjunctivitis and rhinitis, and requires cross‐organ treatment. This study assessed the impact of the coronavirus disease 2019 (COVID‐19) pandemic on HF treatment trends.
Yasutsugu Akasaki   +27 more
wiley   +1 more source

Measurement of Japanese Cedar Pollen-Specific IgE in Nasal Secretions

open access: yesAllergology International, 2014
Background: : Japanese cedar pollen (JCP) is the most common allergen for seasonal allergic rhinitis in Japan. Little is known about local production of immunoglobulin (Ig)E in people with or without Japanese cedar pollinosis. The aims of this study were
Hiroshi Sakaida   +2 more
doaj   +1 more source

Climate change from the Asia‐Pacific perspective: What an allergist needs to know and do

open access: yesPediatric Allergy and Immunology, Volume 35, Issue 8, August 2024.
Abstract Allergic diseases such as asthma, atopic dermatitis, and food allergies are a burgeoning health challenge in the Asia‐Pacific region. Compounding this, the region has become increasingly susceptible to the impacts of climate change. The region has weathered extreme precipitation, intense heat waves, and dust storms over the recent decades ...
Amanda Zain   +3 more
wiley   +1 more source

Roles of omalizumab in various allergic diseases

open access: yesAllergology International, 2020
IgE and mast cells play a pivotal role in various allergic diseases, including asthma, allergic rhinitis, and urticaria. Treatment with omalizumab, a monoclonal anti-IgE antibody, has significantly improved control of these allergic diseases and ...
Yoshimichi Okayama   +5 more
doaj   +1 more source

CRISPR/Cas9-mediated disruption of CjACOS5 confers no-pollen formation on sugi trees (Cryptomeria japonica D. Don)

open access: yesScientific Reports, 2023
Sugi (Cryptomeria japonica D. Don) is an economically important coniferous tree in Japan. However, abundant sugi pollen grains are dispersed and transported by the wind each spring and cause a severe pollen allergy syndrome (Japanese cedar pollinosis ...
Mitsuru Nishiguchi   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy